|
Federal
Register Notices > Notices
of Application - 2003 > Sigma Aldrich Research Biochemicals, Inc.
FR Doc 03-29963 [Federal Register: December 2,
2003 (Volume 68, Number 231)] [Notices] [Page 67479-67480] From the
Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02de03-106]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Application
Pursuant to section 1301.33(a) of title 21 of the
Code of Federal Regulations (CFR), this is notice that on September 18,
2003, Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road,
Natick, Massachusetts 01760, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk manufacturer
of the basic classes of controlled substances listed below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| Aminorex (1585) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide
(7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 4-Bromo-2,5-dimethoxy-amphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymethamphetamine
(MDMA) (7405) |
I |
| 1-[1-(2-thienyl)cyclohexyl]piperidine
(TCP) (7470) |
I |
| Heroin (9200) |
I |
| Normorphine (9313) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Ecgonine (9180) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Metazocine (9240) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Carfentanil (9743) |
II |
| Fentanyl (9801) |
II |
The firm plans to manufacture the listed
controlled substances for laboratory reference standards and
neurochemicals.
Any other such applicant and any person who is
presently registered with DEA to manufacture such substance may file
comments or objections to the issuance of the proposed
registration.
Any such comments or objections may be addressed,
in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, United States
Department of Justice, Washington, DC 20537, Attention: Federal Register
Representative, Office of Chief Counsel (CCD) and must be filed no later
than February 2, 2004.
November 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-29963 Filed 12-01-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
